Business process improvement/strategic planning

Ended Awarded Last action

Contract number
75F40122F19012
Awardee
Awarding agency
Obligated
$6,211,527

Award facts

Contract value 51% obligated
  • $6,211,527.11 Current, with exercised options
  • $12,203,581.61 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
North Bethesda, MD 20852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00008 · EOI::defend the spend::EOI termination for convenience agreement. The purpose of this modification is to DE-obligate funds, cancel non-funded items 2, 4, 6,… -$499,121
Terminate for Convenience P00007 · EOI::defend the spend::EOI termination for convenience agreement $0
Other Administrative Action P00006 $423,891
Other Administrative Action P00005 $998,174
Other Administrative Action P00004 $1,000,888
Exercise an Option P00003 $1,441,426
Exercise an Option P00002 $1,404,844
Other Administrative Action P00001 $0
Original award $1,441,426

About this award

This contract award represents a termination for convenience modification to a Business Process Improvement/Strategic Planning Blanket Purchase Agreement (BPA) call under the General Services Administration (GSA) Multiple Award Schedule (MAS), awarded to Booz Allen Hamilton Inc. by the Food and Drug Administration (FDA). Originally valued at approximately $12.2 million with an ultimate completion date of April 1, 2025, the modification de-obligates remaining funds and formally closes the contract by canceling non-funded line items. The work is performed at the FDA's headquarters location in Rockville, Maryland. This contract leverages the MAS vehicle, a government-wide acquisition contract that enables federal agencies to efficiently procure professional services from pre-competed vendors without conducting individual full and open competitions.

Under this engagement, Booz Allen Hamilton provided strategic consulting and business process improvement services to support FDA operations. The prime contractor engaged Parab Consulting Group Inc. (Pcgi), an SBA-certified 8(a) Program Participant and woman-owned small business, as a subcontractor to deliver business and technology consulting services, including system integration, database implementation, customer relationship management (CRM) systems, data warehouse development, master data management, reporting infrastructure, data analytics, digital tools, and artificial intelligence capabilities. The termination for convenience closure reflects a standard contract administration action to reconcile funding and formally conclude the engagement.

Quick answers

Who was awarded contract 75F40122F19012?

75F40122F19012 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on August 29, 2022.

How much is contract 75F40122F19012 worth?

The government has obligated $6,211,527 on 75F40122F19012. Its potential value, with all options, is $12,203,582.

Is contract 75F40122F19012 an order under another contract?

Yes. 75F40122F19012 is a BPA call under GS00F008DA-75F40122A00008, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40122F19012 competed?

The extent of competition for 75F40122F19012 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award